Literature DB >> 16807245

Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide.

Lillian Zernichow1, Magnus Abrink, Jenny Hallgren, Mirjana Grujic, Gunnar Pejler, Svein O Kolset.   

Abstract

It has recently been shown that serglycin is essential for maturation of mast cell secretory granules. However, serglycin is expressed also by other cell types, and in this study we addressed the role of serglycin in macrophages. Adherent cells were prepared from murine peritoneal cell populations and from spleens, and analyzed for proteoglycan synthesis by biosynthetic labeling with [35S]sulfate. Conditioned media from serglycin-/- peritoneal macrophages and adherent spleen cells displayed a 65-80% reduction of 35S-labeled proteoglycans, compared with corresponding material from serglycin+/+ cells, indicating that serglycin is the dominant secretory proteoglycan in macrophages of these origins. In contrast, the levels of intracellular proteoglycans were similar in serglycin+/+ and serglycin-/- cells, suggesting that serglycin is not stored intracellularly to a major extent in macrophages. This is in contrast to mast cells, in which serglycin is predominantly stored intracellularly. Transmission electron microscopy revealed that the absence of serglycin did not cause any major morphological effects on peritoneal macrophages, in contrast to dramatic defects in intracellular storage vesicles in peritoneal mast cells. Several secretory products were not found to be affected by the lack of serglycin. However, the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide stimulation was markedly higher in serglycin-/- cultures than in those of serglycin+/+. The present report thus demonstrates that serglycin is the major proteoglycan secreted by peritoneal macrophages and suggests that the macrophage serglycin may have a role in regulating secretion of tumor necrosis factor-alpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807245     DOI: 10.1074/jbc.M512889200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Biological implications of preformed mast cell mediators.

Authors:  Anders Lundequist; Gunnar Pejler
Journal:  Cell Mol Life Sci       Date:  2010-11-11       Impact factor: 9.261

2.  Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1.

Authors:  Astri J Meen; Inger Øynebråten; Trine M Reine; Annette Duelli; Katja Svennevig; Gunnar Pejler; Trond Jenssen; Svein O Kolset
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

3.  Serglycin protects against high fat diet-induced increase in serum LDL in mice.

Authors:  Astri J Meen; Christian A Drevon; Gunnar Pejler; Trond G Jenssen; Ole Kristoffer Olstad; Magnus Åbrink; Svein O Kolset
Journal:  Glycoconj J       Date:  2015-09-21       Impact factor: 2.916

4.  Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.

Authors:  Anurag Purushothaman; Bryan P Toole
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 5.  A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens.

Authors:  Hannah Tomlin; Anna M Piccinini
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

6.  Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity.

Authors:  Teresa Greenwell-Wild; Niki M Moutsopoulos; Maria Gliozzi; Efstathia Kapsogeorgou; Zoila Rangel; Peter J Munson; Haralampos M Moutsopoulos; Sharon M Wahl
Journal:  Arthritis Rheum       Date:  2011-10

7.  Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells.

Authors:  Tiago Braga; Mirjana Grujic; Agneta Lukinius; Lars Hellman; Magnus Abrink; Gunnar Pejler
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

Review 8.  Heparan sulfate proteoglycans.

Authors:  Stephane Sarrazin; William C Lamanna; Jeffrey D Esko
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

9.  Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.

Authors:  Donna S Woulfe; Joanne Klimas Lilliendahl; Shelley August; Lubica Rauova; M Anna Kowalska; Magnus Abrink; Gunnar Pejler; James G White; Barbara P Schick
Journal:  Blood       Date:  2007-12-19       Impact factor: 22.113

10.  Control of promatrilysin (MMP7) activation and substrate-specific activity by sulfated glycosaminoglycans.

Authors:  Hyun-Jeong Ra; Susanna Harju-Baker; Fuming Zhang; Robert J Linhardt; Carole L Wilson; William C Parks
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.